Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allergenix was a specialized preclinical contract research organization (CRO) based in Perth, Australia, that focused on respiratory and allergic disease models. The company was renowned for its proprietary sheep model of asthma, which provided a high degree of translational relevance to human lung physiology and disease pathology. Allergenix offered a range of services to global pharmaceutical and biotechnology partners, including efficacy testing, aerosol drug delivery optimization, and detailed lung function analysis. The company's models were instrumental in the preclinical evaluation of several major respiratory therapies, including monoclonal antibodies and novel small molecules. Although the company is no longer active as a standalone commercial entity, its research contributions and models remain highly regarded in the respiratory research community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allergenix.